Method of treating malignant neoplastic disease
US3968249A · kind A · utility
10Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 1968 |
| Grant date | Jul 6, 1976 |
| Priority date | — |
| Expiry date | May 15, 1988 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to pharmaceutical preparations and the method of utilizing them in the treatment of malignant neoplastic diseases. The administration of hydroxyurea or 1-ethyl-1-hydroxyurea has been found to be effective for the amelioration of the symptoms of various forms of leukemia, carcinoma or sarcoma in various organs of the body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.